Sánchez-Vergara J

Idioma: Español
Referencias bibliográficas: 26
Paginas: 160-166
Archivo PDF: 180.28 Kb.

FRAGMENTO

La evaluación prequirúrgica del paciente oncológico sigue las mismas directrices que la población quirúrgica en general. Sin embargo, sabemos que la fisiología del paciente oncológico se altera a consecuencia del cáncer, del tratamiento antineoplásico o por los dos factores. Nos referiremos a las alteraciones en los sistemas orgánicos principales, por su frecuencia de afección, así como la importancia de estos sistemas en el período transoperatorio. No se debe dejar pasar por alto la noción de que toda la economía se afecta en menor o mayor grado y que los efectos de los quimioterápicos también son muy amplios, haciendo aquí mención solamente de algunos de ellos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Shoemaker. Medical complications in the cancer patient. In: Textbook of Critical Care, Ed Saunders, 2000.

2. Chan KK, et al. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis. Cancer Res 1980;40:1263.

3. Pierre MK. Heart disease and cancer. In: Critical care of the cancer patient. Howland WS, Carlon GC (Eds). Chicago, Year Book Medical Publishers, 1985:61-85.

4. Parvinen LM, et al. Factors affecting the pulmonary toxicity of bleomycin. Acta Radiol 1983;22:417.

5. Waid-Jones MI, Coursin DB, Perioperative considerations for patients treated with bleomycin. Chest 1991;99:993.

6. Friedman MA, Carter JB. Serious toxicities associated with chemotherapy. Semin Oncol 1978;5:193.

7. Rosenow EC III: The spectrum of drug induced pulmonary disease. Ann Intern Med 1972;77:977.

8. Salaffi F, et al. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature. Clin Rheumatol 1997;16:296.

9. Kriesman H, et al. Pulmonary toxicity of antineoplasic therapy. Semin Oncol 1992;19:508-520.

10. Goldiner PL, et al. Factors influencing post-operative morbidity and mortality in patients treated with bleomycin. Br Med J 1978;1:664.

11. Eagle K, Brundage B, Chaitman B, et al. Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery: AHA/ACC task force report. J Am Coll Cardiol 1996;27:910–948.

12. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline update for perioperative cardiovascular evaluation for noncardiac surgery: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002;94:1052–1064.

13. Ali MJ, Davison P, Pickett W, et al. ACC/AHA guidelines as predictors of postoperative cardiac outcomes. Can J Anaesth 2000;47:10-19.

14. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006;113:1361-1376.

15. Tamul PC, Peruzzi DOWT. Assessment and management of patients with pulmonary disease. Crit Care Med 2004;32:S137–S145.

16. Madjdpour, et al. Anemia and perioperative red blood cell transfusion: A matter of tolerante. Crit Care Med 2006;34:S102-S108.

17. Dzankic, Pastor D, Gonzalez C, et al. The prevalence and predictive value of abnormal preoperative laboratory tests in elderly surgical patients. Anesth Analg 2001;93:301-308.

18. Howell, et al. Br J Anaesth 2004;92:570-83.

19. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and allcause mortality, and to longevity: findings from long-term followup of Chicago cohorts. Cardiology 1993;82:191-222.

20. Howell SJ, Hemming AE, Allman KG, Glover L, Sear JW, Foex P. Predictors of postoperative myocardial ischaemia. The role of intercurrent arterial hypertension and other cardiovascular risk factors. Anaesthesia 1997;52:107-11.

21. Liao YL, Liu KA, Dyer A, et al. Major and minor electrocardiographic abnormalities and risk of death from coronary heart disease, cardiovascular diseases and all causes in men and women. J Am Coll Cardiol 1988;12:1494-500.

22. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 1999;100:354-60.

23. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). 2002.

24. Coursin DB, et al. Perioperative diabetic and hyperglycemic management issues. Crit Care Med 2004;32:S116-S125.

25. Gu W, et al. Modifying cardiovascular risk in diabetes mellitus. Anesthesiology 2003;98:774-779.

26. Finney, et al. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047.